AMLID Tablets 10 Milligram
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
29-04-2024
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
AMLODIPINE MALEATE
थमां उपलब्ध:
Pinewood Laboratories Ltd,
डोज़:
10 Milligram
फार्मास्यूटिकल फॉर्म:
Tablets
प्राधिकरण की तारीख:
2005-07-22
उत्पाद विशेषताएं
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Amlid 10 mg tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 10 mg amlodipine (as amlodipine maleate).
Excipients: Each 10 mg tablet also contains 138 mg lactose.
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Tablet
The tablets are white, round and biconvex, scored on both sides.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Hypertension
Chronic stable angina pectoris
Vasospastic (Prinzmetal’s) angina
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults
For both hypertension and angina the usual initial dose is 5 mg Amlid once daily which may be increased to a
maximum dose of 10 mg depending on the individual patient's response.
In hypertensive patients, Amlid has been used in combination with a thiazide diuretic, alpha blocker, beta blocker, or an
angiotensin converting enzyme inhibitor. For angina, Amlid may be used as monotherapy or in combination with other
antianginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta
blockers.
No dose adjustment of Amlid is required upon concomitant administration of thiazide diuretics, beta blockers, and
angiotensin-converting enzyme inhibitors.
Special populations
Elderly
Amlid used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are
recommended in the elderly, but increase of the dosage should take place with care (see sections 4.4 and 5.2).
Hepatic impairment
Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore
dose selection should be cautious and
पूरा दस्तावेज़ पढ़ें
